Organization | Bausch Health Companies

Bausch Health Companies Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4

Founded: Costa Mesa CA United States (1959)

Organization Overview

First Clinical Trial

1999

NCT00000772

First Marketed Drug

1959

ergoloid mesylate

First NDA Approval

1961

chlordiazepoxide (librium)

Last Known Activity

2024

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BAUSCH | Bausch Health | Bausch Health Americas, Inc. | Bausch Health, Canada Inc. | Bausch Health Companies | Bausch Health Companies, INC. | Bausch Health Ireland Limited | BAUSCH HEALTH IRELAND LIMITED | Bausch Health US, LLC | BAUSCH HEALTH US, LLC | BAUSCH LOMB IRELAND | ICN Biomedicals | ICN Pharmaceuticals | ICN Pharmaceuticals (v1) | ICN Pharmaceuticals (v2) | Medical Monitor, Valeant Pharmaceuticals | Ortho Dermatologics | Valeant | VALEANT | Valeant/Bausch & Lomb | VALEANT BERMUDA | Valeant Canada Limited | VALEANT INTL | VALEANT LUXEMBOURG | Valeant Pharmaceitucals | Valeant Pharmaceutical | Valeant Pharmaceutical NA | Valeant Pharmaceuticals | Valeant Pharmaceuticals/Bausch & Lomb Incorporated | Valeant Pharmaceuticals International, Inc. | Valeant Pharmaceuticals Luxembourg S.Ã .r.l. | Valeant Pharmaceuticals NA | Valeant Pharmaceuticals, NA | Valeant Pharmaceuticals North America LLC | VALEANT PHARM INTL | VALEANT PHARMS | VALEANT PHARMS INC | VALEANT PHARMS INTL | VALEANT PHARMS LLC | VALEANT PHARMS NORTH | Valeant Russia, LLC | Yvonne Romero

Active Ingredients

Marketed Drugs (132)

Key: Bausch Health Companies (90) Acquired (42)

acetaminophen (tylenol) (1985)

acetylsalicylic acid (aspirin) (1964)

aciclovir (zovirax) (1982 NDA)

adapalene (differin) (2023)

albuterol (proventil) (1998)

aminophylline (aminophyllin) (1976)

atropine (2022)

balsalazide (colazal) (2000)

benoxinate (2020)

benzoyl peroxide (clearasil) (2000)

bexarotene (targretin) (1999)

brimonidine (alphagan) (2017)

brinzolamide (azopt) (2021)

brodalumab (siliq) (2017 NDA)

budesonide (rhinocort) (2013)

bupropion (wellbutrin) (2008)

butalbital (fiornal) (1985)

caffeine (1964)

chlordiazepoxide (librium) (1961 NDA)

chlorhexidine (hibitane) (2018)

ciclopirox (loprox) (1999)

clidinium (quarzan) (1966)

clindamycin (cleocin) (2000)

codeine (Phenergan) (2001)

cromoglicic acid (Intal) (2000)

desirudin (Ipravask) (2003)

desmopressin (ddavp) (2017)

dexamethasone (2008)

diazepam (valium) (1997)

dihydroergotamine (D.H.E. 45) (1946)

diltiazem (cardizem) (1982 NDA)

diphenhydramine (benadryl) (1974)

diphenoxylate (1997)

doxycycline (vibramycin) (2005)

edetic acid (1953 NDA)

efinaconazole (jublia) (2014)

enalapril (vasotec) (1985)

ergoloid mesylate (1946)

erythromycin (ilosone) (1984)

etacrynic acid (1967)

ezogabine (potiga) (2011 NDA)

famotidine (pepcid) (1986 NDA)

fenofibrate (fenoglide) (2012)

flucytosine (ancobon) (1971 NDA)

flunisolide (nasalide) (2002)

fluocinonide (lidex) (2005)

fluorescein (2020)

fluorouracil (efudex) (1970 NDA)

fluoxymesterone (1981)

flurazepam (dalmane) (1970)

griseofulvin (grisactin) (1975)

hydrochlorothiazide (esidrix) (1986)

hydrocortisone (solu-cortef) (1982)

hydroxypropyl cellulose (Lacrisert) (1981)

imiquimod (aldara) (1997)

ipratropium (atrovent) (2001)

isoprenaline (1956)

isopropyl alcohol (2018)

isosorbide (isordil) (1959)

ketotifen (zaditor) (2020)

latanoprost (xalatan) (2017)

levodopa (larodopa)

levorphanol tartrate (levo-dromoran) (1953 NDA)

lorazepam (ativan) (1977)

loteprednol (lotemax) (2019)

luliconazole (luzu) (2013)

meprobamate (equanil)

mesalamine (rowasa) (2008)

methazolamide (neptazane) (2018)

methoxsalen (1954)

methylnaltrexone (relistor) (2016)

methyltestosterone (testred) (1973 NDA)

metronidazole (flagyl) (1997)

metyrosine (demser) (1979)

minocycline (minocin) (1972)

monobenzone (benoquin) (1952 NDA)

nabilone (cesamet) (1985)

nifedipine (procardia) (2000)

nitroglycerin (transderm-nitro) (1988)

olopatadine (patanol) (2017)

orphenadrine hydrochloride (disipal) (1959)

pegaptanib (macugen) (2004)

penicillamine (cuprimine) (1970)

pentobarbital (nembutal) (1974)

pentoxifylline (trental) (1998)

perfluorohexyloctane (Miebo) (2023 NDA)

pergolide (permax) (1988)

phendimetrazine (plegine) (1976)

phenylacetic acid (ucephan) (2005)

phytonadione (konakion) (1955)

pimecrolimus (elidel) (2001)

pirbuterol (maxair) (1986)

plecanatide (trulance) (2017)

polyethylene glycol (2018)

potassium chloride (klor-con) (2018)

prednicarbate (dermatop) (1991 NDA)

prednisolone (hydeltra) (2002)

prednisone (meticorten)

primidone (mysoline) (1954 NDA)

propoxyphene (Darvon)

pyridostigmine bromide (mestinon) (1955 NDA)

quinidine (1977)

rauwolfia alkaloids

reserpine (serpasil) (1976)

ribavirin (virazole) (1985)

secobarbital (seconal) (1981)

selegiline (zelapar) (2006)

sertaconazole (ertaczo) (2003)

sodium benzoate (AMMONUL) (2005)

sodium chloride (2018)

sodium sulfate (2018)

sulfacetamide (sultrin) (1996)

sulfisoxazole (gantrisin)

tazarotene (tazorac) (2019)

testosterone (delatestryl) (2014)

tetrabenazine (xenazine) (2008)

tetracaine (pontocaine) (2019)

tetracycline (tetrex)

timolol (blocadren) (1978)

tolcapone (tasmar) (1998 NDA)

tramadol (Ultram) (2005)

tretinoin (Retin-A) (1971)

triamcinolone (kenalog) (2021)

triethylenetetramine (trientine) (1985)

trioxsalen (trisoralen) (NDA)

ulobetasol propionate (Ultravate) (2018)

urea (1971)

vamorolone (Agamree) (2023 NDA)

venlafaxine (effexor) (2011)

verteporfin (visudyne) (2000)

vitamin c (2018)

Drugs in Phase 4 Trials (65)

Key: Bausch Health Companies (20) Acquired (45)

adapalene (differin) (6 trials)

benzoyl peroxide (clearasil) (15 trials)

bepotastine (bepreve) (10 trials)

besifloxacin (besivance) (15 trials)

bexarotene (targretin) (1 trial)

brodalumab (siliq) (6 trials)

bromfenac (xibrom) (14 trials)

budesonide (rhinocort) (11 trials)

bupropion (wellbutrin) (3 trials)

chlorhexidine (hibitane) (14 trials)

clindamycin (cleocin) (12 trials)

colesevelam (welchol) (1 trial)

cyclosporine (sandimmune) (3 trials)

dapsone (aczone) (1 trial)

efinaconazole (jublia) (4 trials)

erythromycin (ilosone) (1 trial)

ethanol (2 trials)

ezetimibe (zetia) (1 trial)

ezogabine (potiga) (6 trials)

flecainide (tambocor) (1 trial)

fluocinolone acetonide (synalar) (6 trials)

fluocinonide (lidex) (5 trials)

ganciclovir (cytovene) (2 trials)

halobetasol (ultravate) (11 trials)

hyaluronic acid (2 trials)

hyaluronidase (ovine) (Vitrase) (7 trials)

idebenone (17 trials)

imiquimod (aldara) (22 trials)

indomethacin (indocin) (1 trial)

iodine (3 trials)

isopropyl alcohol (11 trials)

ketorolac (acuvail) (3 trials)

lactulose (cephulac) (2 trials)

latanoprost (xalatan) (10 trials)

loperamide (imodium) (1 trial)

loteprednol (lotemax) (27 trials)

luliconazole (luzu) (5 trials)

mesalamine (rowasa) (8 trials)

methylene blue (proveblue) (3 trials)

methylnaltrexone (relistor) (46 trials)

minocycline (minocin) (5 trials)

moxifloxacin (avelox) (7 trials)

mupirocin (bactroban) (1 trial)

nabilone (cesamet) (6 trials)

naltrexone (revia) (2 trials)

nepafenac (nevanac) (3 trials)

omeprazole (prilosec) (6 trials)

pegaptanib (macugen) (15 trials)

perfluorohexyloctane (Miebo) (2 trials)

polyethylene glycol (3 trials)

povidone-iodine (betadine) (3 trials)

prednisone (meticorten) (5 trials)

ribavirin (virazole) (12 trials)

rifaximin (xifaxan) (38 trials)

rimabotulinumtoxinB (Myobloc) (4 trials)

selegiline (zelapar) (1 trial)

sodium bicarbonate (3 trials)

sodium chloride (7 trials)

sodium phosphate (1 trial)

tazarotene (tazorac) (10 trials)

testosterone (delatestryl) (12 trials)

tobramycin (nebcin) (9 trials)

tretinoin (Retin-A) (19 trials)

urea (4 trials)

verteporfin (visudyne) (2 trials)

Drugs in Phase 3 Trials (36)

Key: Bausch Health Companies (12) Acquired (24)

aciclovir (zovirax) (1 trial)

alpha-lipoic acid (1 trial)

balsalazide (colazal) (3 trials)

brimonidine (alphagan) (6 trials)

celecoxib (celebrex) (1 trial)

cimetidine (tagamet) (1 trial)

crofelemer (mytesi) (4 trials)

desmopressin (ddavp) (6 trials)

diclofenac (voltaren) (1 trial)

diisopropyl adipate (1 trial)

ecabet (3 trials)

flibanserin (addyi) (14 trials)

formoterol (foradil) (1 trial)

gatifloxacin (Zymar) (4 trials)

interferon alfacon-1 (Infergen) (2 trials)

interferon alpha-2b (Intron-A) (3 trials)

ketotifen (zaditor) (6 trials)

mapracorat (8 trials)

metronidazole (flagyl) (2 trials)

multivitamins (1 trial)

naphazoline (visine) (3 trials)

olopatadine (patanol) (1 trial)

pimecrolimus (elidel) (2 trials)

plecanatide (trulance) (11 trials)

resorcinol (1 trial)

rifamycin (aemcolo) (3 trials)

risedronate (actonel) (1 trial)

sipuleucel-t (Provenge) (21 trials)

Taribavirin (4 trials)

tetrabenazine (xenazine) (2 trials)

timolol (blocadren) (5 trials)

tizanidine (zanaflex) (1 trial)

tramadol (Ultram) (9 trials)

ulobetasol propionate (Ultravate) (8 trials)

Drugs in Phase 2 Trials (40)

Key: Bausch Health Companies (10) Acquired (30)

abiraterone (zytiga) (2 trials)

acetylcysteine (mucomyst) (1 trial)

adefovir dipivoxil (hepsera) (2 trials)

albuterol (proventil) (1 trial)

allogeneic adipose derived mesenchymal stem cell (1 trial)

amiselimod (1 trial)

antiprimod (5 trials)

apalutamide (erleada) (1 trial)

brinzolamide (azopt) (1 trial)

cb-10-01 (1 trial)

cellulose (2 trials)

desoximetasone (topicort) (1 trial)

dn24-02 (1 trial)

edetic acid (1 trial)

enzalutamide (xtandi) (2 trials)

fibrinolysin, human (2 trials)

fipamezole (2 trials)

fluconazole (diflucan) (1 trial)

flucytosine (ancobon) (1 trial)

fluticasone (cutivate) (2 trials)

fosphenytoin (Cerebyx) (1 trial)

fulvic acid (1 trial)

hypidone (2 trials)

hypromelloses (1 trial)

idp-107 (2 trials)

idp-115 (1 trial)

jnj 10229570 (1 trial)

leuprolide (lupron) (1 trial)

liposomal annamycin (2 trials)

metyrosine (demser) (1 trial)

pdi-192 (1 trial)

pdi-320 (1 trial)

petrolatum, white (Vaseline) (1 trial)

platelet-rich plasma (1 trial)

pol6014 (1 trial)

pradefovir (2 trials)

resiquimod (6 trials)

san-300 (1 trial)

sp-333 (2 trials)

vamorolone (Agamree) (2 trials)

Drugs in Phase 1 Trials (43)

Key: Bausch Health Companies (4) Acquired (39)

89zr-tlx250 (1 trial)

acetylsalicylic acid (aspirin) (2 trials)

amlodipine (norvasc) (2 trials)

atezolizumab (Tecentriq) (1 trial)

bg505 sosip.664 gp140 (1 trial)

capsaicin (qutenza) (1 trial)

carvedilol (coreg) (2 trials)

cefadroxil (duricef) (2 trials)

coptis chinesis (1 trial)

d-3263 (1 trial)

didanosine (videx) (1 trial)

donepezil (aricept) (1 trial)

epinephrine (levophed) (1 trial)

esomeprazole (nexium) (2 trials)

estradiol (progynon depot) (2 trials)

famotidine (pepcid) (1 trial)

flurbiprofen (ansaid) (1 trial)

ginseng (1 trial)

glu-xx (1 trial)

glycerol phenylbutyrate (ravicti) (2 trials)

griseofulvin (grisactin) (2 trials)

hht120 (1 trial)

ilex kudingcha (1 trial)

meloxicam (mobic) (2 trials)

menadiol (synkavite) (1 trial)

midazolam (versed) (1 trial)

naloxone (narcan) (1 trial)

norethindrone (2 trials)

omigapil (1 trial)

paroxetine (paxil) (1 trial)

phenylacetic acid (ucephan) (1 trial)

polyacrylamide (1 trial)

polymyxin b sulfate (poly-rx) (1 trial)

pravastatin (pravachol) (2 trials)

salmeterol (serevent) (1 trial)

sitagliptin (januvia) (2 trials)

sodium benzoate (AMMONUL) (1 trial)

sodium phenylbutyrate (buphenyl) (1 trial)

stearic acid (1 trial)

sumatriptan (zecuity) (1 trial)

tiotropium (spiriva) (5 trials)

trandolapril (mavik) (1 trial)

transgenic lymphocyte immunization vaccine (1 trial)

Drugs in Other Trials (20)

Key: Bausch Health Companies (9) Acquired (11)

aflibercept (zaltrap) (1 trial)

benzocaine (Orajel) (1 trial)

bifidobacterium lactis (1 trial)

desitin (1 trial)

dihydroergotamine (D.H.E. 45) (1 trial)

fluorouracil (efudex) (1 trial)

hydromorphone (diladid) (1 trial)

iodine povacrylex (DuraPrep Surgical) (2 trials)

Lactobacillus acidophilus (1 trial)

lactobacillus casei (1 trial)

lidocaine (xylocaine) (1 trial)

neomycin (1 trial)

ondansetron (zofran) (1 trial)

pergolide (permax) (1 trial)

pf-04878691 (1 trial)

sodium lauryl sulfate (1 trial)

tetracaine (pontocaine) (1 trial)

triamcinolone (kenalog) (1 trial)

triethylenetetramine (trientine) (1 trial)

water (1 trial)

Indications

Approved Indications

Angina Pectoris

Arthritis, Rheumatoid

Breast Neoplasms

Colonic Neoplasms

Epilepsies, Partial

Epilepsy, Complex Partial

Epilepsy, Tonic-Clonic

Epstein-Barr Virus Infections

Herpes Genitalis

Herpes Labialis

Hypopigmentation

Meningitis, Cryptococcal

Migraine Disorders

Myasthenia Gravis

Parkinson Disease

Puberty, Delayed

Pulmonary Infarction

Stomach Neoplasms

Urinary Tract Infections

Experimental Indications (Clinical Trials, Phases 1-4)

Acne Vulgaris (Phase 4)

Acquired Immunodeficiency Syndrome (Phase 4)

Adenocarcinoma (Phase 2)

Alzheimer Disease (Phase 2)

Arthritis (Phase 3)

Arthritis, Psoriatic (Phase 3)

Arthritis, Rheumatoid (Phase 2)

Back Pain (Phase 3)

Brain Diseases (Phase 4)

Carcinoma (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Cataract (Phase 3)

Chronic Pain (Phase 3)

Clostridium Infections (Phase 3)

Colitis (Phase 4)

Colitis, Ulcerative (Phase 4)

Colonic Diseases (Phase 2)

Communicable Diseases (Phase 4)

Conjunctivitis (Phase 4)

Conjunctivitis, Allergic (Phase 4)

Conjunctivitis, Bacterial (Phase 3)

Constipation (Phase 4)

Crohn Disease (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Diarrhea (Phase 4)

DiGeorge Syndrome (Phase 2)

Digestive System Diseases (Phase 2)

Dysentery (Phase 4)

Eczema (Phase 3)

Epilepsy (Phase 3)

Esophagitis (Phase 4)

Esophagitis, Peptic (Phase 4)

Eye Pain (Phase 1)

Fever (Phase 2)

Fibromyalgia (Phase 2)

Fibrosis (Phase 4)

Gastroesophageal Reflux (Phase 4)

Gastrointestinal Diseases (Phase 2)

Gastrointestinal Hemorrhage (Phase 3)

Gastroparesis (Phase 4)

Glaucoma (Phase 2)

Hemangioma (Phase 2)

Hemangioma, Capillary (Phase 2)

Hemorrhage (Phase 3)

Hemorrhagic Fever, Crimean (Phase 2)

Hemorrhagic Fevers, Viral (Phase 2)

Hepatic Encephalopathy (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 3)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 3)

Hepatitis, Chronic (Phase 3)

Hernia (Phase 3)

Hernia, Ventral (Phase 3)

Hidradenitis (Phase 2)

Hidradenitis Suppurativa (Phase 2)

HIV Enteropathy (Phase 3)

HIV Infections (Phase 4)

HIV Seropositivity (Phase 1)

Hypersensitivity (Phase 2)

Hypertension (Phase 2)

Ileus (Phase 3)

Immune System Diseases (Phase 4)

Immunologic Deficiency Syndromes (Phase 4)

Infections (Phase 4)

Inflammation (Phase 4)

Inflammatory Bowel Diseases (Phase 3)

Intestinal Diseases (Phase 3)

Irritable Bowel Syndrome (Phase 3)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Lassa Fever (Phase 2)

Lennox Gastaut Syndrome (Phase 3)

Lentivirus Infections (Phase 4)

Liver Cirrhosis (Phase 2)

Liver Diseases (Phase 4)

Low Back Pain (Phase 3)

Lymphoma (Phase 4)

Lymphoma, T-Cell (Phase 4)

Lymphoma, T-Cell, Cutaneous (Phase 4)

Macular Degeneration (Phase 4)

Macular Edema (Phase 4)

Mental Disorders (Phase 2)

Multiple Sclerosis (Phase 4)

Muscle Spasticity (Phase 2)

Myofascial Pain Syndromes (Phase 2)

Nausea (Phase 4)

Neoplasms (Phase 4)

Neuralgia (Phase 4)

Neuralgia, Postherpetic (Phase 2)

Obesity (Phase 4)

Ocular Hypertension (Phase 2)

Onychomycosis (Phase 4)

Osteoarthritis (Phase 3)

Pancreatic Neoplasms (Phase 3)

Parkinson Disease (Phase 4)

Phantom Limb (Phase 2)

Port-Wine Stain (Phase 2)

Postoperative Complications (Phase 1)

Premature Birth (Phase 3)

Premature Ejaculation (Phase 3)

Proctitis (Phase 3)

Proctocolitis (Phase 3)

Prostatic Neoplasms (Phase 3)

Psoriasis (Phase 4)

Psychotic Disorders (Phase 2)

Radiculopathy (Phase 3)

Renal Insufficiency (Phase 1)

Retinal Vein Occlusion (Phase 4)

Rosacea (Phase 3)

Sclerosis (Phase 4)

Seizures (Phase 4)

Sexually Transmitted Diseases (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 2)

Syndrome (Phase 3)

Tinea (Phase 4)

Tinea Pedis (Phase 4)

Tourette Syndrome (Phase 2)

Ulcer (Phase 4)

Uveitis (Phase 3)

Vomiting (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 615
# of Trial APIs: 204